Table 1.
Name | Potential role | Ref. |
---|---|---|
MCL-1 | It is associated with the degree of inflammation and TNF-α level in addition to inhibiting the apoptosis of FLS. | (21) |
PDCD5 | It is negatively correlated with CRP, ESR, IL-17, and TNF-α levels. | (49, 50) |
β2-R | It is negatively correlated with disease severity. | (89) |
Cell-free nucleosomes | It is associated with disease severity. | (156, 157) |
Myeloperoxidase | It is associated with disease severity. | (156, 157) |
Neutrophil elastase | It is associated with disease severity. | (156, 157) |
MPO-DNA complex | It is associated with ACPA and RF levels. | (158) |
Calprotectin | It is associated with the serum markers of inflammation, CRP, ESR, and baseline levels of anti-CCP, as well as predicting the progression of joint destruction and drug efficacy. | (162, 163) |
14-3-3η | It is closely associated with disease severity and anti-cyclic citrullinated peptide antibody levels. | (172) |
IL-18 | It is associated with inflammation. | (183) |
SNP of NLRP3 | It is related to RA susceptibility and response to anti-TNF-α therapy. | (188) |